Ritonavir

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9643 publications

Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs.

Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs.

Journal: Biomacromolecules
Published: January 19, 2026

Regioselective multicomponent synthesis of α-boryl ureas: discovery of a potent main protease inhibitor.

Regioselective multicomponent synthesis of α-boryl ureas: discovery of a potent main protease inhibitor.

Journal: Organic & biomolecular chemistry
Published: January 14, 2026

Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.

Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 07, 2026

Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically diverse Caenorhabditis nematodes.

Computer prediction and genetic analysis identifies retinoic acid modulation as a driver of conserved longevity pathways in genetically diverse Caenorhabditis nematodes.

Journal: eLife
Published: December 23, 2025

Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir.

Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir.

Journal: Journal of medical economics
Published: December 13, 2025

Polypharmacy and nephrotoxicity

Polypharmacy and nephrotoxicity

Journal: Innere Medizin (Heidelberg, Germany)
Published: December 05, 2025

A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 - present).

A patent review of Mpro protease inhibitors for the treatment of COVID-19 infections (2020 - present).

Journal: Expert opinion on therapeutic patents
Published: December 05, 2025

Computational Insights into the Regioselective Hydroxylation of Nirmatrelvir Metabolized by Cytochrome P450 3A4.

Computational Insights into the Regioselective Hydroxylation of Nirmatrelvir Metabolized by Cytochrome P450 3A4.

Journal: Journal of chemical information and modeling
Published: November 27, 2025

EXPRESS: Early Blood RNA Clearance and Protein Fraction Profiles Predict Treatment Outcomes in Cats with Effusive FIP.

EXPRESS: Early Blood RNA Clearance and Protein Fraction Profiles Predict Treatment Outcomes in Cats with Effusive FIP.

Journal: Journal of feline medicine and surgery
Published: November 26, 2025

Risk factors associated with anti-tubercular therapy-induced hepatitis in human immunodeficiency virus seropositive and seronegative patients in India.

Risk factors associated with anti-tubercular therapy-induced hepatitis in human immunodeficiency virus seropositive and seronegative patients in India.

Journal: The International journal of risk & safety in medicine
Published: November 24, 2025

Identification and characterization of a SARS-CoV-2 M pro G23 deletion ensitrelvir-resistant mutant.

Identification and characterization of a SARS-CoV-2 M pro G23 deletion ensitrelvir-resistant mutant.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Coronaviruses main proteases and their inhibitors.

Coronaviruses main proteases and their inhibitors.

Journal: The Enzymes
Published: November 14, 2025
Showing 1-12 of 9,643

Last Updated: 02/24/2026